The development and validation of a coated bead immunoassay for amniotic fluid acetylcholinesterase is outlined. The assay has good precision (between assay CV of 6·H% within the normal range), and is linear up to 250 arbitrary units/L. The clinical validity of this assay has been assessed using a panel of amniotic fluid samples from normal and abnormal pregnancies. At an assay cut off level of 200 arbitrary units/L, all cases of neural tube defect-affected pregnancies were identified and the number of false positives was very small. False positives resulted from severe blood staining of the amniotic fluid. Since the monoclonal antibody used recognises red cell membrane acetylcholinesterase and the stored amniotic fluids had been frozen and thawed a number of times: the extent of this problem needs to be further assessed using freshly collected samples. The performance of this assay was found to be superior to the differential inhibitor colorimetric method and close to that of the electrophoretic procedure. The quantitative nature of the assay and the independence from operator technique makes it a useful adjunct to the measurement of amniotic fluid AFP in the prenatal diagnosis of neural tube defects.
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Measurement of amniotic fluid alphafctoprotein (AFP) is a widely used test for the antenatal diagnosis of neural tube defects. I. 2 However, the test may yield both false positive and false negative results.I The number of false positive and false negative results based on the AFP result may be reduced by carrying out a second confirmatory test.
Amniotic fluid acetylcholinesterase (AChE) measured by polyacrylamide gel electrophoresis has been shown to be a useful adjunct to the AFP test in reducing the number of false positive results." However. the gel electrophoretic method has several disadvantages mainly due to the poor separation of the neural AChE band from the non specific cholinesterase band. Furthermore. the technique is qualitative. requires considerable technical skill and experience, and interpretation is operator-dependent.
A sensitive quantitative technique for measuring low levels of AChE using the substrate analogue acetylthiocholine has been described by ElIman 4 and applied to amniotic Correspondence: Mr K Spencer. fluid AChE measurement by Smith et u/.sand many other groups. Accurate determination of the enzyme activity requires correction for the non-enzymic hydrolysis of the substrate. Measurement of AChE in the presence of nonspecific cholinesterase depends on the use of inhibitors.
Lysivane, which suppresses pseudocholinesterases. and BW 2lWC51. whieh suppresses AChE. are the most commonly employed. Unfortunately. neither of these inhibitors is absolutely specific and it is therefore difficult to differentiate AChE activity from total activity of all other cholinesterases. As a result. false positive results have been obtained!' in samples contaminated by maternal blood where the non specific cholinesterase activity is very high and the red cell membranebound AChE may also contribute.
Recently, enzyme immunoassays for AChE in amniotic fluid have been described?' II and shown to be useful in reducing the AFP based false positive and false negative results. Both methods used antisera raised against human erythrocyte AChE. which has been shown to cross react with neuromuscular junctions. In one case the antiserum was polyclonal? and, in the other, monoclonal." In each methods, the antibody was coated onto microtitre plates, followed by antigen adsorption, washing and subsequent enzymic analysis using the Ellman 4 procedure. Hence the methods require the use of special equipment such as plate washers and microtitre plate readers which are not readily available in most hospital biochemistry departments.
In order to assess the suitability of this type of assay procedure in a routine neural tube defect (NTD) screening centre we have investigated the development of a coated bead immunoassay which may have wide applicability in routine screening and be useful as an adjunct to the AFP test in the diagnosis of neural tube defect affected pregnancies.
Materials and methods

METHOD DEVEI.OPMENT
Monoclonal antibody to AChE (AE-2) was obtained as a gift from Dr David Brock, Human Genetics Unit, Western General Hospital, Edinburgh. The antibody (in ascitic fluid) was raised against erythrocyte AChE and shown to cross-react with human neuromuscular junctions.' } Polystyrene beads with their surfaces modified by amino groups (aminodylark beads) were obtained from Sekisui Chemical Company Ltd, Windsor, Berkshire.
Vertical rod polyacrylamide gel electrophoresis of amniotic fluid was carried out to identify the AChE isoenzyme pattern. The procedure used was that described by Brock and Hayward. ((I The basic principle of the coated bead enzyme immunoassay used was as follows. Polystyrene beads were precoated with anti mouse immunoglobulin (Dako Ltd, High Wycombe, Bucks.) at 1 in 100dilution in carbonate buffer (0,01 rnol/L, pH 9·6, 200 fA.L per bead) for 2 h on a roller mixer. The beads were washed three times with 400 fA.L phosphate buffered saline (0·01 mol/L phosphate, pH 7·0, 0·1 moltL sodium chloride, 0·05% Tween 20). The beads were blotted dry and further incubated with a 1 in 2S00 dilution of the monoclonal anti-AChE antibody in carbonate buffer (0,01 mol/L, pH 9,6) for 2 h on a roller mixer at room temperature. The beads were washed again three times in phosphate buffered saline and blotted dry.
For the immunoassay, ISO fA.L of standard or sample was incubated for 20 h at 30"C with one bead per tube. The beads were washed three times with 400 fA.L phosphate buffered saline and blotted dry. The assay was completed by the addition of 2·S mL of freshly prepared enzyme reagent (2·3 mmoUL acetylthiocholine iodide, l·S mmol/L DTNB (5,S'-dithiobis (2nitrobenzoic acid» in O'OS moUL phosphate buffer, pH 7·S) and incubated for 2 h at 30"C.
To correct for non-enzymatic hydrolysis of the substrate a blank was set up by incubating an antibody coated bead with phosphate buffered saline in place of the sample. The spectrophotometer was set to zero using the blank sample and the absorbance of the standards and tests then read at 40S nm.
The assay parameters were investigated using dilutions of a pool of amniotic fluid from a neural tube defect affected pregnancy. For calibration of the assay a human serum pool was used with an assigned value of WOO arbitrary (arb.) units per litre. Dilutions of this standard covering the range SO to 250 arb. unitslL were prepared in phosphate buffered saline.
Results
ASSAY OPTIMISATION
Antibody coating
Antibody dilution. The effect of AChE antibody concentration on its binding to aminodylark beads was investigated using two concentrations of human serum AChE (100 arb. unitslL and 2S0 arb. unitslL). The results are shown in Fig. I and this indicates that the optimum antibody concentration was at a dilution of I in 2S00.
Incubation time. The effect of incubation time for the coating of anti-AChE onto aminodylark beads was investigated at two anti AChE dilutions, with a serum AChE activity of SOO arb. unitslL. 1'he results (Fig. 2) indicate a rapid binding of the antibody to the beads with 91°1<. of the antibody bound within the first 2 h. Extending the incubation period by another 2 h would only increase the binding by a further 2% and this extra gain was considered minimal for the additional time spent. Therefore an incubation time of 2 h was considered suitable for coating of the beads.
Temperature. An increase in temperature is known to influence protein binding onto surfaces, therefore, the optimum temperature for coating anti-AChE was investigated at an antibody dilution of I in 2500. The results indicated ; 0·08 s c:
.. that binding increased with increasing temperature up to 22°C, but at 37°C the calibration curve gave a non-linear response. It was decided that coating of the beads could be adequately accomplished at room temperature. pH. The effect of pH on adsorption of proteins onto surfaces has been studied by many workers, who have found binding to be dependent on both physical properties of the surface and the protein itself. The effect of pH on antibody coating of the beads was investigated at a 1 in 2S()() dilution of the anti-AChE. The pH optimum was found to be pH 9·6.
Antigen antibody reaction
Having established the optimum conditions for coating the anti-AChE onto the aminodylark beads. the next stage was to determine the optimum conditions for maximum binding of the fluid AChE to the the antibody coated beads.
Temperature. Figure 3 shows the results obtained on incubating the antibody-coated beads with AChE in human serum at various temperatures. Binding of the antigen to the antibody increased with temperature. However. non-specificbinding (NSB) as determined by the absorbance value at the abscissa also increases with temperature. It was decided to use a temperature of 30"C, being a compromise between greater signal change and the need for lower NSB's. Incubation time. An increase in binding between antibody-coated beads and AChE was seen with increasing incubation times as shown in Fig. 4 . At 20 h the reaction has reached 90% of that at 24 h, .and it was decided to use 20 h for this incubation stage since this would enable the assay to be completed in a 24 h period. stoichiometry. Figure 5 shows the relationship between DTNB concentration and absorbance measured at 405 nm. Non-enzymic reactions appear to increase as the DTNB concentration increases which results in a confused optimisation picture. It was decided that a DTNB concentration of 1·5 mmol/L was probably the most suitable level to be used. Incubation time, The reaction was studied at various incubation periods from I to 4 h. Extending the incubation time from 2 to 4 h produced a change equivalent to an increase from 4 to 5·4x III~arb. units of AChE. The extra sensitivity obtained by prolonging the incubation time to 4 h was felt to be insignificant and an incubation period of 2 h was used.
Incubation temperature. The colour development reaction was studied at 22°C, 30°C and 37°C. Whilst 37°C gave the greatest signal response, the calibration curve was non-linear. At 3(rC the signal achieved was J()' Yo less than at 37°C, but the calibration curve showed a linear response.
Assay validation
Precision. Within and between assay precision was determined using an amniotic fluid sample from a normal pregnancy (Control I) and also from an anencephalic pregnancy diluted 1 in 3 with phosphate buffered saline (Control 2). The controls were aliquoted into 25() ",L .amounts and stored at -200C until required. Table 1 shows within and between assay precision to be less than 7%.
Specificity and interference. Contamination of amniotic fluid by non-specific cholinesterases, erythrocyte AChE and bovine AChE was investigated in an attempt to determine the specificity of the assay. Fresh adult blood (rich in butyrylcholinesterase) was mixed with amniotic fluid from a pregnancy of normal outcome to give a range of samples with levels of contamination varying from W to ().()o1'Yo. Fresh adult blood was frozen and thawed and mixed with amniotic fluid in a similar way. as was fetal calf serum. Neat amniotic fluid and the mixed samples prepared above were assayed. in duplicate. by the standard procedure. Figure 6 shows the effect of relative contamination from these sources. A very small increase in the absorbance value occurred when blood constituted J()'Yo of the amniotic fluid, indicating that non-specific cholinesterase do not contribute to the assay. However. a marked increase in absorbance was seen when amniotic fluid was contaminated with more than 1% freeze-thawed blood. as a result of interaction with increased levels of red cell membranebound AChE. Foetal calf serum showed considerable contamination effects at levels as low as ()·l%.
Clinical validation
Amniotic fluid samples from women identified by our neural tube defect maternal serum AFP screening program as being of a high risk of carrying a neural tube defected affected foetus.
were collected by transabdominal amniocentesis during the second trimester of the pregnancy. The amniotic fluid samples were centrifuged at 300()g for W min on receipt and the supernatants stored in aliquots at -20°C prior to analysis. Data on pregnancy outcome was recorded after termination or after delivery.
The samples were assayed on arrival for AFP by a polyethylene glycol precipitated radioimmunoassayI I and for AChE by the quantitative colorimetric method using Iysivane as inhibitor of non-specific cholinesterase and carried out on a Cobas Bio centrifugal analyser (Roche Diagnostics Ltd, Welwyn Garden City, Herts, UK). The amniotic fluid specimens were classified into "three categories: (i) Normal outcome pregnancies with amniotic fluid AFP levels less than the gestational 99th centile and with normal AChE results (normals).
(ii) Normal outcome pregnancies with amniotic fluid AFP levels greater than the gestational 99th centile and/or abnormally elevated AChE levels by the colorimetric method (Reference range 2,2-9·4 iuIL). (False positives).
(iii) Pregnancies with an abnormal outcome, either neural tube related or non-neural tube related.
The AChE levels were measured by the enzyme immunoassay procedure in 307 clear amniotic fluid specimens from pregnancies with a normal outcome. The mean level was found to be 59 arb. unitslL with a ±2 SD range of 124 arb. unitslL. A further 28 samples with blood stained amniotic fluids from normal pregnancies and 40 cases of pregnancy with some form of neural lesion were also analysed together with six non-NTD related abnormalities. The results of these assays (383 samples in total) are depicted in Fig. 4 . Of the 28 blood stained fluids, only four (14%) had levels greater than 200 arb. unitslL.
Using 200 arb. unitslL as a cut-off level, 37 out of 40 (92·5%) neural tube defect affected pregnancies were correctly classified. The three false negative results occurred in amniotic fluid samples from pregnancies where the fetus had anencephaly with a covering membrane, one closed spina bifida and one inencephaly. Of 343 specimens from non-NTD pregnancies, six false positives were found (1·75%). Two of these were cases of exomphalos and four were heavily blood contaminated samples. Table 2 summarises the results obtained using the colorimetric AChE assay, the polyac-" rylamide gel electrophoretic procedure and the proposed enzyme immunoassay. The predictive value of a positive result for each assay was 46·8%, 92·9%, and 86·0%, respectively. The predictive value of a negative result for each assay was 99·0%, 99·1%, and 99·1%, respectively. The efficiency for NTD detection for each assay was 88·3%, 99·0%, and 97·7%, respectively. Clearly, the enzyme immunoassay is far superior in clinical discrimination to the colorimetric assay and has very similar clinical performance to the electrophoretic procedure.
With respect to the AFP levels, 14 false positive results were identified from 383 preg- 
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This work is part of an MSc in Clinical Biochemistry (University of Surrey) submitted by S M. We thank Dr D Brock for the gift of Antenatal diagnosis of neural tube defects 575 with blood, thereby increasing the level of pseudocholinesterases. Thus, although the colorimetric assay is simple to perform and can be easily automated, its lack of specificity in our hands, and those of others," renders the test unsuitable for the diagnosis of NTD's.
Of the six false positive results obtained by the enzyme immunoassay for AChE, two were from pregnancies where the fetus had an exomphalos. Here, the exposure of blood vessels in the extruding viscera may be responsible for 'leaking' the AChE into the amniotic fluid. Heavily blood contaminated specimens also gave positive results. The specimens were freeze-thawed, and hence could have released erythrocyte membrane bound AChE into the amniotic fluid. Hence, in order to determine the true specificity of the assay, it would be essential to use only fresh or clear amniotic fluid specimens. However, the enzyme immunoassay appears to be far superior to the colorimetric method and comparable to the gel electrophoretic method in terms of. diagnostic specificity for NTD's.
Three neural tube defect pregnancies were not detected by the enzyme immunoassay. In all three cases, secretion of AChE into the amniotic fluid was prevented by a physical barrier between the fetal circulation and the amniotic fluid. A covering membrane was present in the anencephalic case, while the inencephalic and closed spina bifida cases did not show any exposure of the neural tube. Two of these did have a raised amniotic fluid AFP (anencephaly and closed spina bifida). The gel electrophoretic method did . not correctly classify these cases either.
. . Clearly, the enzyme immunoassay method has diagnostic superiority over the colorimetric assay and is almost as good as that of the electrophoretic assay. The precise, accurate, quantitative and non operator biased enzyme immunoassay .in our hands presents a much more reliable and convenient measure of amniotic fluid AChE than any other assay and confirms the findings of Brock et al. ll using the same antibody in a microtitre plate assay. We would propose that this type of assay be used to supplement all measurements of amniotic fluid AFP. * 34 • )250 ....
•
Discussion
In NTD screening there is clearly a need to reduce the number of amniotic fluid-based false positives by the use of a second confirmatory test. Acetylcholinesterase, originating from exposed neural tissue, would be expected to give more precise information on the presence of a neural tube defect in the fetus. The diagnostic value of the AChE test however, appears to be dependent on the method of detection.
In this study 42 false positive AChE results were obtained when the amniotic fluid specimens were assayed by the colorimetric method. This lack of specificity can be attributed mainly to the use of the inhibitor lysivane, which is not absolutely complete in its inhibition of pseudocholinestrases. False positive results will be obtained when amniotic fluid is contaminated monoclonal antibody to acetylcholinesterase. This study was funded in part by a grant from the Wand M Morris Trust.
